Interferon-gamma release assays (IGRAs) are significantly better than tuberculin skin tests (TST) at predicting progression from latent tuberculosis (TB), a new meta-analysis from Germany shows.

Latent tuberculosis appears to protect people from developing active TB if they're reinfected, Boston-based researchers report.